Skip to main content

Pharmacopeial Forum Table of Contents

View the current Pharmacopeial Forum (PF) Table of Contents. For older PF tables of contents, visit our archive.

Select from the below links to access PF content. A free resource, PF visitors must create a user name and password.

PF 44(3) Table of Contents Publish date: April 30, 2018

PROPOSED IRA

Proposed Interim Revision Announcements

IN-PROCESS REVISION

In-Process Revision

GENERAL CHAPTERS

<64> PROBIOTIC TESTS [NEW] (USP42-NF37 1S)
<671> CONTAINERS-PERFORMANCE TESTING (USP42-NF37 1S)
<795> PHARMACEUTICAL COMPOUNDING-NONSTERILE PREPARATIONS (USP42-NF37 1S)
<1151> PHARMACEUTICAL DOSAGE FORMS (USP42-NF37 1S)
<1226> VERIFICATION OF COMPENDIAL PROCEDURES (USP42-NF37 1S)
<1671> THE APPLICATION OF MOISTURE VAPOR TRANSMISSION RATES FOR SOLID ORAL DOSAGE FORMS IN PLASTIC PACKAGING SYSTEMS [NEW] (USP42-NF37 1S)
<1850> EVALUATION OF SCREENING TECHNOLOGIES FOR ASSESSING MEDICINE QUALITY [NEW] (USP42-NF37 1S)

REAGENTS, INDICATORS, AND SOLUTIONS

Reagent Specifications

2-Acetylresorcinol [NEW] (USP42-NF37 1S)
(p-tert-Octylphenoxy) nonaethoxyethanol (USP42-NF37 1S)

Indicators

Eriochrome Black T (USP42-NF37 1S)

Indicator Test Papers

Litmus Paper, Neutral [NEW] (USP42-NF37 1S)

Test Solutions

0.2% Phosphoric Acid TS [NEW] (USP42-NF37 1S)

Volumetric Solutions

0.1 N Ammonium Thiocyanate VS (USP42-NF37 1S)
0.02 M Zinc Sulfate VS [NEW] (USP42-NF37 1S)

Chromatographic Columns

G51 [NEW] (USP42-NF37 1S)
L86 (USP42-NF37 1S)
L118 [NEW] (USP42-NF37 1S)

REFERENCE TABLES

Container Specifications

Container Specifications [NEW] (USP42-NF37 1S)

Description and Solubility

Description and Relative Solubility of USP and NF Articles (USP42-NF37 1S) 
Description and Solubility - D 
Description and Solubility - N 
Description and Solubility - T

USP MONOGRAPHS

Amcinonide (USP42-NF37 1S)
Amcinonide Cream (USP42-NF37 1S)
Amcinonide Ointment (USP42-NF37 1S)
Amiloride Hydrochloride and Hydrochlorothiazide Tablets (USP42-NF37 1S)
Aminobenzoate Potassium for Oral Solution (USP42-NF37 1S)
Amiodarone Hydrochloride Injection (USP42-NF37 1S)
Amiodarone Hydrochloride Tablets [NEW] (USP42-NF37 1S)
Amoxicillin and Clavulanate Potassium for Oral Suspension (USP42-NF37 1S)
Amoxicillin and Clavulanate Potassium Tablets (USP42-NF37 1S)
Azithromycin Tablets (USP42-NF37 1S)
Belladonna Leaf (USP42-NF37 1S)
Belladonna Extract (USP42-NF37 1S)
Belladonna Extract Tablets (USP42-NF37 1S)
Belladonna Tincture (USP42-NF37 1S)
Benztropine Mesylate (USP42-NF37 1S)
Benztropine Mesylate Injection (USP42-NF37 1S)
Benztropine Mesylate Tablets (USP42-NF37 1S)
Budesonide Nasal Spray [NEW] (USP42-NF37 1S)
Cefazolin Ophthalmic Solution (USP42-NF37 1S)
Ciprofloxacin Ophthalmic Ointment (USP42-NF37 1S)
Ciprofloxacin Ophthalmic Solution (USP42-NF37 1S)
Clindamycin Phosphate (USP42-NF37 1S)
Clonazepam (USP42-NF37 1S)
Clonazepam Tablets (USP42-NF37 1S)
Cocaine and Tetracaine Hydrochlorides and Epinephrine Topical Solution (USP42-NF37 1S)
Corticotropin Injection (USP42-NF37 1S)
Corticotropin for Injection (USP42-NF37 1S)
Repository Corticotropin Injection (USP42-NF37 1S)
Cromolyn Sodium Oral Solution [NEW] (USP42-NF37 1S)
Dextrose (USP42-NF37 1S)
Diclofenac Potassium for Oral Solution [NEW] (USP42-NF37 1S)
Diclofenac Sodium Topical Gel [NEW] (USP42-NF37 1S)
Digitalis (USP42-NF37 1S)
Powdered Digitalis (USP42-NF37 1S)
Digitalis Capsules (USP42-NF37 1S)
Digitalis Tablets (USP42-NF37 1S)
Fluconazole Tablets (USP42-NF37 1S)
Fluvastatin Capsules (USP42-NF37 1S)
Gadoterate Meglumine Injection [NEW] (USP42-NF37 1S)
Galantamine Extended-Release Capsules (USP42-NF37 1S)
Galantamine Oral Solution (USP42-NF37 1S)
Galantamine Tablets (USP42-NF37 1S)
Galantamine Hydrobromide (USP42-NF37 1S)
Glucagon (USP42-NF37 1S)
Guanfacine Hydrochloride (USP42-NF37 1S)
Hydrocortisone Acetate (USP42-NF37 1S)
Hydrocortisone Acetate Cream (USP42-NF37 1S)
Hydroxychloroquine Sulfate Tablets (USP42-NF37 1S)
Milk of Magnesia (USP42-NF37 1S)
Magnesium Hydroxide Paste (USP42-NF37 1S)
Mesoridazine Besylate Oral Solution (USP42-NF37 1S)
Methotrexate for Injection (USP42-NF37 1S)
Methylcellulose Ophthalmic Solution (USP42-NF37 1S)
Methylcellulose Oral Solution (USP42-NF37 1S)
Methyldopa Oral Suspension (USP42-NF37 1S)
Methyldopa and Chlorothiazide Tablets (USP42-NF37 1S)
Methylene Blue Injection, Veterinary (USP42-NF37 1S)
Methylprednisolone (USP42-NF37 1S)
Methylprednisolone Acetate Cream (USP42-NF37 1S)
Methylprednisolone Hemisuccinate (USP42-NF37 1S)
Methysergide Maleate (USP42-NF37 1S)
Methysergide Maleate Tablets (USP42-NF37 1S)
Metyrapone Tablets (USP42-NF37 1S)
Mezlocillin Sodium (USP42-NF37 1S)
Mezlocillin for Injection (USP42-NF37 1S)
Miconazole Injection (USP42-NF37 1S)
Minocycline Hydrochloride Oral Suspension (USP42-NF37 1S)
Moricizine Hydrochloride Tablets (USP42-NF37 1S)
Morrhuate Sodium Injection (USP42-NF37 1S)
Nabumetone Tablets (USP42-NF37 1S)
Nafcillin Sodium Capsules (USP42-NF37 1S)
Nafcillin Sodium for Oral Solution (USP42-NF37 1S)
Nafcillin Sodium Tablets (USP42-NF37 1S)
Nalidixic Acid (USP42-NF37 1S)
Nalidixic Acid Oral Suspension (USP42-NF37 1S)
Nalidixic Acid Tablets (USP42-NF37 1S)
Naproxen Compounded Oral Suspension [NEW] (USP42-NF37 1S)
Netilmicin Sulfate (USP42-NF37 1S)
Netilmicin Sulfate Injection (USP42-NF37 1S)
Nilotinib [NEW] (USP42-NF37 1S)
Diluted Nitroglycerin (USP42-NF37 1S)
Nitroglycerin Injection (USP42-NF37 1S)
Nitroglycerin Ointment (USP42-NF37 1S)
Nitroglycerin Sublingual Tablets (USP42-NF37 1S)
Nitromersol (USP42-NF37 1S)
Norethindrone Acetate and Ethinyl Estradiol Tablets (USP42-NF37 1S)
Norfloxacin (USP42-NF37 1S)
Norfloxacin Ophthalmic Solution (USP42-NF37 1S)
Norfloxacin Tablets (USP42-NF37 1S)
Norgestrel Tablets (USP42-NF37 1S)
Omeprazole Oral Suspension (USP42-NF37 1S)
Omeprazole and Sodium Bicarbonate for Oral Suspension [NEW] (USP42-NF37 1S)
Oxacillin Sodium Capsules (USP42-NF37 1S)
Oxacillin Sodium for Oral Solution (USP42-NF37 1S)
Oxaliplatin Injection (USP42-NF37 1S)
Oxazepam Tablets (USP42-NF37 1S)
Pantoprazole Oral Suspension (USP42-NF37 1S)
Paroxetine Hydrochloride (USP42-NF37 1S)
Probucol (USP42-NF37 1S)
Probucol Tablets (USP42-NF37 1S)
Ranolazine [NEW] (USP42-NF37 1S)
Ranolazine Extended-Release Tablets [NEW] (USP42-NF37 1S)
Selamectin (USP42-NF37 1S)
Sitagliptin and Metformin Hydrochloride Tablets [NEW] (USP42-NF37 1S)
Sitagliptin and Metformin Hydrochloride Extended-Release Tablets [NEW] (USP42-NF37 1S)
Sorafenib Tosylate [NEW] (USP42-NF37 1S)
Stavudine for Oral Solution (USP42-NF37 1S)
Tetrabenazine [NEW] (USP42-NF37 1S)
Tetraxetan [NEW] (USP42-NF37 1S)
Triamcinolone Acetonide Lotion (USP42-NF37 1S)
Triamcinolone Acetonide Injectable Suspension (USP42-NF37 1S)
Xylometazoline Hydrochloride (USP42-NF37 1S)
Xylometazoline Hydrochloride Nasal Solution (USP42-NF37 1S)

DIETARY SUPPLEMENT MONOGRAPHS

Astaxanthin Esters (USP42-NF37 1S)
Creatine [NEW] (USP42-NF37 1S)
Cyanocobalamin Chewable Gels [NEW] (USP42-NF37 1S)
Omega-3 Free Fatty Acids [NEW] (USP42-NF37 1S)

STAGE 4 HARMONIZATION

Stage 2 Harmonization

NF MONOGRAPHS

Gelatin

STIMULI TO THE REVISION PROCESS

The Complexity of Setting Compendial Specifications for Excipient Composition and Impurities